Target intelligence / Profile preview

Clostridioides difficile surface protein (CWP)

Target
CWP
Molecular classification
Bacterial surface protein, Adhesin, S-layer protein, Enzyme
01

Overview

Clostridioides difficile surface proteins, primarily the Surface Layer Protein A (SlpA), constitute a paracrystalline array that covers the entire bacterial cell. These proteins play a fundamental role in the pathogenesis of C. difficile infection (CDI) by mediating the initial stages of colonization, specifically the adhesion of the bacterium to the host's colonic epithelium (Kirk et al., 2017, PubMed: 28630186). Beyond structural integrity, certain surface proteins like Cwp84 function as proteases that process other cell wall components, while others like Cwp66 act as adhesins (Péchiné et al., 2018, PubMed: 29332434). Because these proteins are highly exposed on the bacterial surface, they are prime targets for the development of vaccines and monoclonal antibodies aimed at preventing colonization and promoting bacterial clearance. Therapeutic strategies targeting these proteins often focus on neutralizing their adhesive properties or inducing a robust humoral immune response to facilitate opsonophagocytosis, thereby reducing the severity and recurrence of CDI (Valneva, 2015, ClinicalTrials.gov: NCT02316470). The diversity of these proteins across different strains remains a challenge for broad-spectrum vaccine efficacy, but they remain a critical focus for non-toxin-based therapeutic interventions (Crobach et al., 2016, PubMed: 27553431).

Other names
Surface layer proteinS-layer proteinCell wall proteinSlpACwp84Cwp66FbpAFliCFliD
02

Mechanism of action

Inhibition of bacterial adhesion to host intestinal epithelium and induction of opsonophagocytic immune responses.

03

Biological functions

AdhesionCell wall organizationColonizationImmune evasionProteolysis
04

Disease associations

Clostridioides difficile infectionPseudomembranous colitisAntibiotic-associated diarrhea
05

Safety considerations

Potential for autoimmune cross-reactivityIncomplete protection due to strain variabilityInjection site reactions for vaccines
06

Interacting drugs

VLA-84

2 more in the full profile.

07

Biomarkers

Anti-SlpA antibody titersGlutamate dehydrogenase (GDH)

Beyond the preview

Go deeper on Clostridioides difficile surface protein (CWP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile surface protein (CWP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call